Zhaoke-Hefei was recognized as “2022 Excellent Enterprise of National Intellectual Property” by the China National Intellectual Property Administration

Zhaoke-Hefei was recognized as “2022 Excellent Enterprise of National Intellectual Property” by the China National Intellectual Property Administration

Recently, the China National Intellectual Property Administration (CNIPA) announced the honours list of “2022 Excellent Enterprise and Role Model Enterprise of China National Intellectual Property”. Having strong innovative capabilities in research and development and well-established intellectual property management system, Zhaoke Pharmaceutical (Hefei) Company Limited (“Zhaoke-Hefei”), a subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) was recognized as “2022 Excellent Enterprise of National Intellectual Property”, only one biopharmaceutical company in Anhui Province was awarded.

ดาวน์โหลดข่าวฉบับเต็ม (PDF)

ที่มา: Lee’s Pharmaceutical Holdings – News & Media

ข่าวสารอื่นๆ

thThai